ScreenerHero

FTREFortrea Holdings Inc. Common Stock

NAS · US · Healthcare · Biotechnology · fortrea.com
18.39USD+1.38%Mkt Cap: 1.75B $P/E: —

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers cli…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap1.75B $
Enterprise Value2.68B $
Revenue (TTM)2.68B $
Gross Profit503.80M $
Net Income (TTM)-986.20M $
Revenue/Share28.75 USD
Last Price18.39 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14.0K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)15.98
PEG0.34
EV/EBITDA27.25
EV/Revenue1.00
P/S0.65
P/B3.30
EPS (TTM)-0.83
EPS (Forward)1.14
52W Range
7.40079% of range21.39
52W High21.39 USD
52W Low7.400 USD
Profitability
Gross Margin18.50%
Oper. Margin2.58%
EBITDA Margin3.67%
Profit Margin-36.21%
ROE-175.01%
ROA-36.31%
Growth
Revenue Growth-4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF113.50M $
CapEx (TTM)25.20M $
FCF Margin10.42%
FCF Yield15.95%
Net Debt949.20M $
Net Debt/EBITDA9.66
Balance Sheet
Debt/Equity1.98
Current Ratio0.96
Quick Ratio0.85
Book Value/Sh5.512 USD
Cash/Share1.773 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.55 USD
Upside (mean)+11.7%
Target Range13.00 USD – 26.00 USD
$13.00+11.7% to mean$26.00
# Analysts11
Ownership
Shares Out.95.10M
Float94.00M
Insiders1.22%
Institutions109.52%
Short Interest
Short Ratio8.0d
Short % Float13.79%
Short % Out.11.74%
Shares Short11.16M
Short (prev mo.)9.77M
Technical
SMA 5017.85 (+3.1%)
SMA 20014.20 (+29.5%)
Beta1.97
S&P 52W Chg18.16%
Avg Vol (30d)1.44M
Avg Vol (10d)1.28M
Technical Indicators
RSI (14)50.9
MACD0.0688
MACD Signal0.2362
MACD Hist.-0.1674
BB Upper20.56 USD
BB Middle18.82 USD
BB Lower17.08 USD
BB Width18.51%
ATR (14)1.076 USD
Vol Ratio (20d)0.48x